A detailed history of American Portfolios Advisors transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, American Portfolios Advisors holds 27,922 shares of EW stock, worth $2.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
27,922
Holding current value
$2.1 Million
% of portfolio
0.1%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$82.37 - $107.29 $2.3 Million - $3 Million
27,922 New
27,922 $2.31 Billion
Q2 2022

Mar 20, 2023

BUY
$86.5 - $128.27 $95,323 - $141,353
1,102 Added 3.95%
29,024 $2.76 Billion
Q1 2022

Mar 21, 2023

BUY
$101.96 - $128.34 $279,982 - $352,421
2,746 Added 9.83%
30,668 $3.61 Billion
Q4 2021

Mar 21, 2023

BUY
$106.37 - $130.68 $1.17 Million - $1.44 Million
11,021 Added 39.47%
38,943 $5.05 Billion
Q3 2021

Mar 22, 2023

BUY
$102.91 - $122.75 $575,266 - $686,172
5,590 Added 20.02%
33,512 $3.79 Billion
Q2 2021

Mar 22, 2023

BUY
$83.84 - $104.76 $293,272 - $366,450
3,498 Added 12.53%
31,420 $3.25 Billion
Q1 2021

Mar 22, 2023

BUY
$78.68 - $90.67 $261,532 - $301,387
3,324 Added 11.9%
31,246 $2.61 Billion
Q4 2020

Mar 22, 2023

BUY
$71.69 - $91.23 $122,446 - $155,820
1,708 Added 6.12%
29,630 $2.7 Billion
Q3 2020

Mar 22, 2023

BUY
$67.19 - $87.44 $34,266 - $44,594
510 Added 1.83%
28,432 $2.27 Billion
Q2 2020

Mar 24, 2023

BUY
$57.54 - $76.95 $961,263 - $1.29 Million
16,706 Added 178.33%
26,074 $1.8 Billion
Q1 2020

Mar 24, 2023

SELL
$52.41 - $81.0 $972,415 - $1.5 Million
-18,554 Reduced 66.45%
9,368 $1.77 Billion
Q4 2019

Mar 24, 2023

SELL
$71.7 - $82.09 $1.11 Million - $1.27 Million
-15,506 Reduced 55.53%
12,416 $2.9 Billion
Q3 2019

Mar 24, 2023

SELL
$61.55 - $75.43 $64,812 - $79,427
-1,053 Reduced 11.15%
8,387 $1.84 Billion
Q2 2019

Mar 24, 2023

SELL
$55.74 - $64.41 $1.03 Million - $1.19 Million
-18,482 Reduced 66.19%
9,440 $1.74 Billion
Q1 2019

Mar 24, 2023

BUY
$47.89 - $64.05 $10,871 - $14,539
227 Added 2.22%
10,443 $2 Billion
Q4 2018

Mar 24, 2023

BUY
$46.41 - $56.94 $440,894 - $540,930
9,500 Added 1326.82%
10,216 $1.56 Billion
Q3 2018

Mar 24, 2023

SELL
$45.7 - $58.03 $1.24 Million - $1.58 Million
-27,206 Reduced 97.44%
716 $125 Million
Q2 2018

Mar 24, 2023

SELL
$42.45 - $51.3 $4,542 - $5,489
-107 Reduced 13.41%
691 $101 Million
Q1 2018

Mar 24, 2023

SELL
$37.19 - $47.45 $1.01 Million - $1.29 Million
-27,124 Reduced 97.14%
798 $111 Million
Q4 2017

Mar 24, 2023

SELL
$33.79 - $39.39 $917,770 - $1.07 Million
-27,161
761 $85.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.